Resultados de la búsqueda 141-150 of 9170 for Ovary

  1. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate the safety and feasibility of concentrated bone marrow aspirate administration after Comprehensive Arthroscopic ...

  2. Síntomas y causas - Mayo Clinic

    No está claro qué causa el cáncer de ovario, aunque los médicos han identificado factores que pueden aumentar el riesgo de padecer la enfermedad. Los médicos ...

  3. Cirugía - Ensayos clínicos - Mayo Clinic

    The objective of this study is to evaluate the image quality and radiation dose of a CT angiography protocol (CTA) using tube potential selection and weight- ...

  4. Oncología (médica) - Ensayos clínicos

    For the purpose of this study we define high grade serous cancers to include invasive cancers arising in the ovary and/or fallopian tubes (FT). Using mass ...

  5. Oncología (médica) - Ensayos clínicos

    For the purpose of this study we define high grade serous cancers to include invasive cancers arising in the ovary and/or fallopian tubes (FT). Using mass ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... ovarian cancer, (7) advanced, unresectable clear cell kidney cancer, (8) advanced, unresectable bladder cancer, (9) advanced, unresectable lung ...

  7. Oncología (médica) - Ensayos clínicos

    Cohort C: Triple-negative breast cancer (TNBC);; Cohort D: Platinum-resistant/refractory epithelial ovarian, primary peritoneal, or fallopian tube cancer ( ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    For the purpose of this study we define high grade serous cancers to include invasive cancers arising in the ovary and/or fallopian tubes (FT). Using mass ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... ovarian cancer, (7) advanced, unresectable clear cell kidney cancer, (8) advanced, unresectable bladder cancer, (9) advanced, unresectable lung ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...